NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

By the way, it seems to me that sometime in the near future DCVax-L ought to receive what will be it's commercial name, anyone have a feel for either the name, or the timing of naming it.

That is an interesting question. My initial thoughts while not very creative, are very logical. I would not change the name at all, and leave it as DCVAX in bold cap, but to remove the "dash L" at the end. This is fully descriptive, already familiar to those following the immunology cancer space, not some artificial meaningless name from the marketing department, and most importantly can be reused for all the coming cancer vaccines for all the other solid cancer indications. The name could have a smaller font word below the DCVAX logo to specify the cancer indication for the vaccine, such as PROSTATE or BRAIN or BREAST or LUNG or PANCREAS etc., directly below. Once in use for multiple indication, this will become a very visible and well known logo, and as a result become a household word. Keep it simple and keep it uniform throughout all the cancers. Once the news does get out to the regular mass media of the breakthrough in GBM, there will be MILLIONS of dollars worth of PR invested by the mass media into the name DCVAX. Why throw that away and start all over? So that it could rhyme in some advertising jingle and easy to rhyme?